ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $65,000 | +3.2% | 44,702 | 0.0% | 0.00% | – |
| Q4 2016 | $63,000 | -14.9% | 44,702 | +5.6% | 0.00% | – |
| Q3 2016 | $74,000 | +2.8% | 42,345 | 0.0% | 0.00% | – |
| Q2 2016 | $72,000 | -13.3% | 42,345 | 0.0% | 0.00% | – |
| Q1 2016 | $83,000 | +6.4% | 42,345 | +3.4% | 0.00% | – |
| Q4 2015 | $78,000 | 0.0% | 40,950 | 0.0% | 0.00% | – |
| Q3 2015 | $78,000 | -53.8% | 40,950 | +12.2% | 0.00% | – |
| Q2 2015 | $169,000 | -1.2% | 36,495 | -6.2% | 0.00% | – |
| Q1 2015 | $171,000 | +39.0% | 38,912 | +10.2% | 0.00% | – |
| Q4 2014 | $123,000 | -35.6% | 35,326 | -22.6% | 0.00% | – |
| Q3 2014 | $191,000 | -28.7% | 45,658 | 0.0% | 0.00% | – |
| Q2 2014 | $268,000 | -39.9% | 45,658 | -35.5% | 0.00% | -100.0% |
| Q1 2014 | $446,000 | +26.3% | 70,753 | +17.3% | 0.00% | 0.0% |
| Q4 2013 | $353,000 | -6.4% | 60,330 | -15.6% | 0.00% | 0.0% |
| Q3 2013 | $377,000 | -17.3% | 71,459 | +20.6% | 0.00% | 0.0% |
| Q2 2013 | $456,000 | – | 59,230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |